and 10 ng/ml of IL-4 for Th2; 30 ng/ml of IL-6, 5 ng/ml of TGFβ, 50 ng/ml IL-23, 10 μg/ml of anti-IL-4 and 10 μg/ml of anti-IFNγ for Th17; 5 ng/ml of TGFβ, 10 μg/ml of anti-IL-4 and 10 μg/ml of anti-IFNγ for Tr; 30 ng/ml of IL-6, 10 μg/ml anti-IFNγ, 10 μg/ml anti-IL-4 and 20 μg/ml anti-TGF-β (1D11) neutralizing Abs for Tfh. IL-4, IL-6, IL-12 and TGFβ were purchased from Peprotech. IL-23 was purchased from R&D. To characterized the in vitro-differentiated CD4 T cells under these conditions, 5 days after activation these cells were restimulated with plate-bound anti-CD3 Ab (5 μg/ml) for 4 hours for real-time PCR analysis, or for 24 hours for cytokine measurement by ELISA. In addition, cells were restimulated with PMA and ionomycin in the presence of Golgi-stop for 5 h, after which Foxp3-, IL-17-and IFNγ-producing cells were analyzed using intracellular staining. Intracellular staining for Foxp3 was performed by using a Foxp3 staining kit (eBioscience).
Retroviral transduction. Naïve CD4 +

CD25
-CD62L hi CD44 lo T cells from OT-II mice were FACS-sorted and activated with Ova peptide and irradiated wild-type splenic APCs under neutral (anti-IFNγ, anti-IL-4 and anti-TGFβ), Tfh (IL-6, anti-IFNγ, anti-IL-4 and anti-TGFβ), Th1 (IL-12, anti-IL-4), Th2 (IL-4, anti-IFNγ), Th17 (TGF-β, IL-6, IL-23, anti-IL-4, anti-IFN-γ) conditions. 24 hours after activation, cells were infected by retroviruses expressing Bcl6, Bcl6-ZF3, Bcl6-ZF5 or control empty vector (containing only IRES-GFP). 4 days after infection, GFP + cells were FACS sorted and restimulated with PMA and ionomycin in the presence of Golgi-stop for 4 h, after which IL-17-and/or IFNγ-expressing cells were analyzed using intracellular staining. Also, GFP + cells were restimulated with anti-CD3 for 4 h, and gene expression was determined by real time RT-PCR.
Reporter assay. RORγ, wild-type Bcl6, Bcl6-ZF3 or Bcl6F-Z5 was cloned into bicistronic retroviral vector pGFP-RV provided by Dr. Ken Murphy at Washington University that contains IRES-regulated GFP. The expression vectors were transfected into EL-4 cells with a luciferase construct containing IL-17 minimal promoter with CNS2 element (3, 4) . The dual-luciferase reporter system (Promega) was used to assay Firefly and Renilla luciferase activity in each sample. Renilla luciferase was used to normalize transfection efficiency and luciferase activity.
Quantitative real-time PCR. Total RNA was prepared from T cells using TriZol regent (Invitrogen). cDNA were synthesized using Superscript reverse transcriptase and oligo(dT) primers (Invitrogen) and gene expression was examined with a Bio-Rad iCycler Optical System using iQ TM SYBR green real-time PCR kit (Bio-Rad Laboratories, Inc.). The data were normalized to β-actin reference. The primers for IL-21, IL-17, IL-17F, IL-4, IFNγ, RORγ, T-bet, total Bcl-6 (with both primers in the coding sequence), exogenous Bcl-6 (with one primer in the coding sequence and one in the 3' untranslated region that is not included in the retroviral vector), IL-6R, and CXCR5 and β-actin were previously described (2, 5) .
Keyhole Limpet Hemocyanin (KLH) Immunization. Bcl6-deficient mice and their wild-type controls (6-8 wk old; three per group) were immunized with KLH (0.5 mg/ml) emulsified in CFA (0.5 mg/ml) at the base of the tail (100 µl each mouse, normalized by body weight). Seven days after immunization, these mice were sacrificed and analyzed individually. The germinal center B cells were determined by staining with FITC-labeled GL7, PE-labeled FAS and PerCPlabeled anti-B220 mAb (Pharmingen). The Tfh cell induction was determined by staining with PerCP-labeled anti-CD4 mAb (Pharmingen) and biotinylated anti-CXCR5 mAb (Pharmingen), followed by APC-labeled streptavidin (Jackson ImmunoResearch Laboratories, Inc.). Sera from immunized mice were collected, and antigen-specific IgM, IgG, IgG2a and IgE antibodies were measured by using ELISA. Briefly, serum samples were added in a 3-fold serial dilution onto plates precoated with 100 µg/ml KLH. To analyze the role of Bcl6 in regulation of T cell responses in vivo, spleen cells from KLH-immunized mice were stimulated in 96-well plates as triplicates with or without KLH. Effector cytokines (IFN-γ, IL-4, IL-17 and IL-22) were analyzed 4 days later by ELISA (Pharmingen).
Adoptive transfer and mixed bone marrow chimera studies. FACS sorted naïve CD4 T cells from wild-type or Bcl6 knockout mice and B cells from wild type mice were mixed at 1:1 ratio. These cells were intravenously transferred into syngenic Rag1 −/− mice (10 × 10 6 cells/mouse). The recipient mice were immunized subcutaneously with 100 μg of KLH protein emulsified in CFA. In Figure 4B , recipient mice were treated with a 300 μg of anti-IL-4 mAbs at the time of immunization (day 0) and on days 2 and 4. Seven days after immunization, spleen cells from the recipient mice were isolated and stained with PerCP-labeled anti-CD4 mAb plus biotinylated anti-CXCR5 mAb, followed by APC-labeled streptavidin, or stained with FITC-labeled GL7, PE labeled FAS and PerCP-labeled anti-B220 mAb. Sera from immunized mice were collected, and antigen-specific IgM, IgG, IgG2a and IgE antibodies were measured by using ELISA. Effector cytokines (IFN-γ, IL-4, IL-17 and IL-22) were analyzed 4 days later by ELISA (Pharmingen).
To generate mixed bone marrow chimera, T cell-depleted bone marrow cells were obtained from B6.SJL (CD45.1) or Bcl6 KO mice and mixed 1:1 ratio before being transferred into irradiated Rag1 -/-mice (10 7 cells/transfer, 750 rad). Eight weeks later, the recipient mice were immunized with KLH and analyzed as above.
Immunohistochemical analysis. Fresh mouse spleen tissues were embedded in OCT and frozen with isopentane in Histobath. Tissue blocks were sliced 6 μm with cryotome. Slides were fixed with acetone cold. Biotin-labeled anti-mouse PNA were applied as primary Ab followed by biotinylated anti-rat secondary Ab and avidin-peroxidase complex reagent. Novared was used as substrate. PNA and other reagent are from Vector Laboratary. Slides for PNA staining were count stained with Hematoxlin. 
